Light Snow 19°
Tag:

Drug Safety

News
FDA Approves First Non-Opioid Pain Drug In 20+ Years—Developed By Boston Drugmaker FDA Approves First Non-Opioid Pain Drug In 20+ Years—Developed By Boston Drugmaker
FDA Approves First Non-Opioid Pain Drug In 20+ Years—Developed By Boston Drugmaker The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing pain signals from reaching the brain. The approval marks the first new class of pain medicine in more than two decades and offers a potential non-addictive alternative to opioids. "Today's approval is a historic milestone f…

SHARE

by Chris Spiker
News
These Over-The-Counter Decongestants Don't Work, FDA Says These Over-The-Counter Decongestants Don't Work, FDA Says
These Over-The-Counter Decongestants Don't Work, FDA Says A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t work, the Food and Drug Administration (FDA) says. This follows an extensive review that found the drug ineffective for treating nasal congestion. Oral phenylephrine, widely marketed in cold and allergy medications, has been in use for decades as a go-to nasal decongestant.  However, an FDA review, backed by last year’s unanimous recommendation from the Nonprescription Drug Advisory Committee, found that phenylephrine in oral form does not deliver effective conge…

SHARE

by Joe Lombardi